Company intelligence / Profile preview

International Drug Development Institute

Ottignies-Louvain-la-Neuve, Wallonia, Belgium

Ownership: Private
Employees: ~150
Development stage: Other

Overview

International Drug Development Institute (IDDI) is a privately held, therapy‑focused contract research organization specializing in regulatory statistics, innovative clinical trial design, randomization and trial supply management, clinical data management, electronic data capture, and advanced biostatistics for Phase I–IV trials across oncology, ophthalmology, CNS, cardiovascular, infectious and rare diseases, biosimilars, and other therapeutic areas.

Industry: Contract Research Organization

Partnerships

Medidata (Rave EDC)Sitero (Mentor RTSM)EvidentIQ (Marvin/ID-base EDC)

Beyond the preview

Go deeper on International Drug Development Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on International Drug Development Institute.

Explore the full profile